NCT04817813 (LIBREAST) is a clinical trial in Breast Cancer, sponsored by Hospital Miguel Servet.

Who is sponsoring NCT04817813?

NCT04817813 is sponsored by Hospital Miguel Servet.

What condition does NCT04817813 study?

NCT04817813 studies Breast Cancer, Liver Metastases, Surgery.

Is NCT04817813 still recruiting?

NCT04817813 is currently status unknown. Last updated 26 March 2021.

Last reviewed 2021-03-26 · How we verify

NCT04817813: LIBREAST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot Study

Status unknown Last updated 26 March 2021

What this trial tests

trial in Breast Cancer in 300 participants. Status unknown.

Timeline

15 March 2021

Primary endpoint
15 June 2021

31 July 2021

Quick facts

Lead sponsor	Hospital Miguel Servet
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	15 March 2021
Primary completion	15 June 2021
Estimated completion	31 July 2021
Sites	1 location across Spain

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Liver Metastases — all drugs for Liver Metastases →
Surgery — all drugs for Surgery →

Sponsor

Hospital Miguel Servet

Who can join

Adults 18 to 100, any sex, with Breast Cancer or Liver Metastases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Breast cancer ranks as the top leading malignant tumors among females, and also accounts for the most common cause of tumor related mortality in females worldwide. Approximately, 20-30% of breast cancer cases develop metastasis, while 50% of patients will suffer from breast cancer liver metastasis. The proper indication for surgical treatment of breast cancer liver metastasis is still a matter of discussion. Surgery is becoming more practical and effective than conservative treatment in improving the outcomes of patients with breast cancer liver metastasis and liver metastasis surgery is included in an onco- surgical strategy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Long-term outcomes after breast cancer liver metastasis surgery: A European, retrospective, snapshot study (LIBREAST STUDY).
Cantalejo-Díaz M, Ramia JM, Álvarez-Busto I, Kokas B, et al · · 2024 · cited 5× · PMID 39243418 · DOI 10.1016/j.suronc.2024.102129

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Hospital Miguel Servet trials

Trials by the same sponsor.

NCT06950905 — Contemplative Practice for Well-being and Self-Deconstruction in Women · NA · recruiting
NCT06904794 — Evaluation of the Gambling Habits of Adolescents and Young Adults Post-COVID-19 and Implementation of a Digital Escape R · NA · recruiting
NCT05956405 — Retraining of the Amygdala and Insula for the Treatment of Persistent Covid · NA · completed
NCT06656065 — IMR-Heart Trasplant Study · recruiting
NCT05317754 — Effectiveness of Four Deconstructive Meditative Practices on Well-being and Self-deconstruction · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04817813 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Miguel Servet
Last refreshed: 26 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04817813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing